PS"33a<<u<<+-1<<n**hAa>#*#>>u0fl* PNHcnuflfl* p4<i> j so 1deg '-QooooCNoodoo(c)oro oo(c) 0.20orooroorooroorooro oN-d 0.300.300.300.20oro oodoro oooorooro (c)odo o o o o o o o o o o o o o o o o o o o o o oo o o CN '--I cn CN mm N " VO VO VO moo N " cn CN cn CN rH o i--io o o O o o o o o O o o o o o O o O o O o o oo o o o o o o o o o o o o o o o o o o o o o oCN cn cn 00 CN ON o N " m00 VO 00 mo oo m N " m VO cn cn mo o o o r-H o rH rH 1 1 T--1 CN rH o o o o o o o oo o o o O o o o o o o o o o o o o o o o o o omin NO m C"~ r"~ in 00 CN o ooo 00 m cn ooin m in N " o o(N CN CN cn c n CN CN NO m VO VO VO r- VO r- cn cn cn cn CN CN CN CNo o o o o o o o o o o o o O o o o o o o O o oo o o o o o o o o o o o o O o o o o o o o o oO O o o o o o o o o o o o o o o o o o o o o orH T-H rH T-H t-H rH rH T--'H 1 H rH rH r - i rH rH rH rH rHO O rH o CN - rH CN CN rH rH H - c n cn cn CN - (c) CN o rH rH oO o (c) CN rH c n CN in m r l- VO VO NO moo cn CN cn CN - o t-h(N cn c n 00 CN ON orH H * in1-H 00 v orH oorH in 20 00i i in N " in vo cn c n in<n in vo in m00 CN o 00o 00 m cn 00 min m r f o o<N CN (N cn cn CN CN VO in VO VO VO r-> NO cn c n cn cn CN CN CN CNcn <N O in o o o in r - VO N " vo VO H - 00 H - o rH N " inr - t" - r - in m VO vo r-H CN t-H rH o O O ON min in m r">>ON ON ON O n ON ON ON ON ON ON ON ON ON ON 00 ON ON ON ON O n ON ON ONO O OC/ I u i C/ I O o o o O o o o o o o o o o o O O o o o>: >! >: i--i 1--1 T--' cn cn cn cn mmin in f " I" - ON ON O s ONQ Q Q Copy 1%Multi oooooooo(c)oo 0.20 oo(c) 0.200.20 oo(c) 0.30 (c)(c)(c) 0.20 (c)(c)(c)(c)(c)(c)(c)(c) 0.300.200.50 (c)(c)(c)(c)i n(c)%TetraoVOo 0.500.20 ooom(c) 0.200.20 om(c) 0.300.30oro 0.200.300.500.900.700.300.800.300.60%Tri o(c)oVOooro 0.300.800.000.50 or-o 0.600.500.900.600.600.80 1.001.20 (c)(c)on oro 0.90%Bi ooin' 6.406.005.505.500 YL oovd 5.70 0013.109.5011.5013.20 (c)(c)12.8013.5011.60 oroi 9.2010.90Total10001000100010001000100010001000100310001000100010001000 (c) (c) (c) l--H 10001000100010001000Multinucleateso o o - <N o <N (N (c) m (c) (N (c) (c) m (N in (c) mTetranucleatesvo in <N in <N <N m m m (N <N m in OV m oo m voTrinucleatesVO T"Hm oo O in vo in ov VO vo 00 (c) <N <N ovBinucleates50 64 60 55 55 r-09 57 72t-HmrH 95mr-H 132 (c)128135 vol--1 T--H(c) 92ov(c)r-HMononucleates940925937937930927 r-HmOv 931922 00moo 894875859843853843875874904 Hr-ooDoseo o o oDMSODMSODMSODMSO (c) (c) (c) 1--H(c) 30 30 30 30 50 50 50 50o o o o o (c) (c) OcOo CN l-H CO1--1(c) CNO o o o o o o Oo o o o o o o oo COCN H CNCOCNt-Ho o o o o o o Oo o o o o o o oco Tf N - l/o COCNCNo o o o o o o oo o o o o o o ocO O s o CNCO or- S O wo wo wo wo CNCOo (c) o o o o o oo o o o o o o oo o o o o o o ohHr-H f-H t-H 1m o (N - CO o CNo COCN t""H CNCOCNHCO t-H WO COCNCNCOO s o (N COt-H OI> S O wo WO WO wo CNCOwo r - ' OO o WO wo<N<N^ r CO CO#'3' r>> VOO s O s O 'n O s O s O s O s O sO (c) o (c) (c) (c) (c) (c)r- t" - r - O s O s Os O soO s<NITable 29. Raw data on mitotic outcome of MCL-5 cells treated with different doses of andrographolide for 48 hours.AuVHHN(r)eNCQX (r)0soH***AV"w00es**HS<<V -*->> AV >>#*u0a*cHsn4>O7300 * pNCQcocococnCN COCOCNCOCNCNCO CN COCOVOOvCNCNcoI/OcoCNCN*r>CNCNCOCNVOCNCOVOOVCNCopy 1o oo oo o>>-H ohH o1--H oo ooo o o O O O o ooCOo"^roCNOO ot-H o oo oCNO o o O o o o ooVOoVOoN "OCOot-HoCNo1--H ooo o O O O o o ooCNoOvOvr> OOV ot-H oo orH ot-HOV OV 0 0 r- ov r-- 0 01 10001000100010001000100010001000r--t o o - T-H ^H o oCO rj- CN o - - o CNVO vo N- CO - CN - O9266 85 79 rHOV 70 r- 0 0, 898 H^Ov0 0606 917 906 92692891770 70 70 7006 06 06 06o43o(Na>33o9-o43&0<L>Ih1"3jacd<uah-Ju<4-1o<DaooaoSSSST3104Ocn<(DPSH%Multi OO(c)ooooo(c)oro 0.60 OCO(c)(c)(c)(c) 0.300.520.52zro%Tetra0.60 ovr>o 0.300.50 oC"~(c)(c)00(c)oro 1.001.550.630.42%Tri oCO(c)o(c)oN"(c)ovo(c)on on0.600.902.27 1.671.38%Bi6.50 ooK 6.90 o00ora12.7011.7012.2011.8610.7410.38Total10001000100010001000100010001000970959944Multinucleateso o o - vo CO (c) CO un TfTetranucleatesvo u~> CO *o r->> 00 T--i (c) t^Hvo TfTrinucleatesCO TT T-Ht-Ht-Hvo OV 22 vot-H COBinucleates65 7069 78t-HCNt-h 127T--H 122 vnT--Htoot-H 98Mononucleates926920924 t-hOv 855851876856 H^00 829825s i sa 3 o o o ooT--H(c) (c) T--A(c) 30 30 30C<*W 292coONCNmNOCONOCOmCOr3-CON "o O o o oCNinCNmmONONCNNOOOt--H o o T^ oNOoO nONo0 0t^ HNOCN t--H T--1 r--H (NT fo NOI- ''r -oH--ACONOoCN ON oV--H o 1--1o922953943 ^HCOON 934NO NO mN"r --H m ONCN ooON ON c-T--Hint--H 201 1 t--H 93 9596 94ILL 830817804 00o0030 50 50 50 50% Apoptotic cells oNO(c)ooo(c)(c)NO(c)(c)oo(c)(c)OO(c)(c)oo(c)(c)OO(c) 0.60 (c)(c)t--H(c)CNh*H(c)(c)t--H(c)0 0(c)'(c)(c)CN% Necrotic cells oNOCO(c)(c)cot--H(c)CN(c)ooCNt--H(c)(c)N "t--H(c)(c)CO(c)NOCN(c)(c)CO^H(c)(c)N "CN(c)(c)COCN(c)(c)inCN(c)ooinCN(c)NOCOco% Viable cellsoooin0 0(c)CNNO0 0(c)(c)0 0(c)NTNOOO(c)CNin0 0(c)CNNO0 0ONONO0 0(c)#H-NO0 0(c)(c)inIN(c)OOinIN(c)(c)N-N-(c)CO(c)N"NOTotal cellsooin(c)(c)m(c)(c)in(c)(c)m(c)(c)in(c)(c)in(c)(c)in(c)(c)m(c)(c)m(c)(c)m(c)(c)in(c)(c)m(c)(c)inApoptoticcells CO CON" N" N" co m NO in N " (c)Necrotic cellsooNOinNOCNNON -NO(c) mNOCONOinNO(c)CNm>>#--imCNONCNooNOt--HViablecells ONCN'"fr comCO CNCO NOCNN- COCOCO CNCON"inINCOONt"~co(c)INCONNOCOCNCNCOo> o (c) SS Q 3OoC/3SQ(c) (c)COCopy 1OV<No o O o o o oo VO CN 'nJ- or--H 1 1o o O o o o o00 o CN CN oo #^ht--1 in CN OV o r-H CNCO c o c o Tf in m mo o o o o o ooo o N" o VO 00 VOVO VO ov 00 VOVOvo VO VO Tf- Tfo O O o o o oo O O o o o oin in in m in in mr - in r - 00 vo r - inOV IT) l--H y--4 ov <Nin r - VO m m VOi--i T"H 1--4 CN CN CN CNT f O CN m c o c nc o <N c o t |- c o c oc o CO c o CN CN CN CNo*omOvCNT3<u<uaIm32'oPSPQQielu* PH5Tv-**Ao"EjPi3aSSwp H3skIwPh<DcoOQPhCN CN iOvomooooin00CZ3Table A33. Raw data of andrographolide-treated AHH-1 cells with 6-thioguanine selection for HPRT mutant detection. Replicates C and D.Oat'S.v&Phm O n03Ui=OjvOSIIio (N (NwPhoo<D(WoQlOCopy 1 296